Explore how adjuvant osimertinib aids in detecting molecular residual disease in resected EGFR-mutated NSCLC, offering ...
Doctors at Delray Medical Center are combining AI and robotics to help detect lung cancer earlier and potentially save more ...
Remains on Track to Initiate an Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma in 2025 ...
Findings on golidocitinib for patients with non-small cell lung cancer whose disease has progressed on anti-PD-1 therapy will ...
The Mirror US on MSN12h
Research links high glycogen levels from Western diets to increased lung cancer tumorsLung cancer tumours have been found to 'feed' off sugar, according to a new study examining the link between diet and lung ...
TNF inhibitor use demonstrates no negative impact on survival among patients recently diagnosed with colorectal, lung or ...
Scientists found that aggressive lung cancer cells create their own electrical network, helping them spread. This unique ...
As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...
Servier announces a strategic worldwide licensing agreement for Black Diamond Therapeutics' BDTX-4933 for solid tumors for an ...
Daily Express US on MSN1d
Lung cancer tumors discovered to grow and 'feed' off a typical dietA new study has found that lung cancer tumors 'feed' off sugar and shed light on the link between diet and the disease.
Discover how diet affects lung cancer risk. Learn about the link between a high-fat, high-sugar diet and lung cancer ...
During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed trials of targeted agents for EGFR-mutant lung cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback